Samir B Amin, MBBS, Ph.D.

Postdoctoral Associate

Farmington, CT

Working in the comparative oncology field to study spontaneous development of glioma in Canis familiaris or dogs with emphasis on characterizing and comparing cancer genome and transcriptome to that in human glioma.

Visit The Verhaak Lab

Contact me at: 860-837-2022

Connect with me:

About Samir B Amin, MBBS, Ph.D.

Dr. Amin received his Ph.D. in cancer computational biology from Baylor College of Medicine, Houston, TX in 01/2017. His thesis work was carried out at the UT MD Anderson Cancer Center, and was focused on understanding long non-coding RNA interactions in the context of chromatin organization using integrated analyses of publically available expression, epigenomic and chromatin interaction data. Before completing Ph.D., Dr. Amin received research training (2008-2011) in computational biology at the Dana-Farber Cancer Institute, Boston, MA where he worked on the assessment of gene expression profiling as predictive biomarker in multiple myeloma. Previously, Dr. Amin received his first professional degree in medicine, MBBS from the Medical College of Maharaja Sayajirao University of Baroda, Vadodara, India in 2005.

Download CV

Education and experience

Education:

Bachelor of Medicine, Bachelor of Surgery (MBBS) 11/1998-03/2005 Maharaja Sayajirao University of Baroda, Vadodara, Gujarat India
Ph.D. 08/2011-01/2017 Cancer Computational Biology, Graduate Program in Structural and Computational Biology & Molecular Biophysics (SCBMB), Baylor College of Medicine, Houston, TX

Experience:

Postdoctoral fellow 2017-Present Verhaak Lab at the Jackson Laboratory for Genomic Medicine, Farmington, CT
Graduate Student 2011-2016 Baylor College of Medicine and the UT MD Anderson Cancer Center, Houston, TX
Research fellow 2008-2011 Dana-Farber Cancer Institute, Boston, MA
Resident physician 2006-2007 Bhailal Amin General Hospital, Vadodara, GJ, India

Honors and accomplishments

Prof. John J. Trentin Award for Scholastic Excellence
2012 Baylor College of Medicine, Houston, TX

Selected Publications

View full list of publications

Tech CornerApril 10, 2018
Cancer and its immune environment bioprinted and reproduced live and in 3D
New 3D bioprinting technique creates a platform for precision immunotherapy study.
Tech CornerApril 05, 2018
Finding the signal in the noise
GeneWeaver is a powerful web-based software system that combines a genomics data repository with powerful analysis tools.
- Genetic Tools
- Genetics and Genomics
Press ReleaseApril 05, 2018
DNA sequence alterations linked to type 2 diabetes genes and mechanisms
Michael Stitzel, Ph.D., a Jackson Laboratory assistant professor, is the senior author of a paper in the American Journal of Human Genetics identifying new genetic clues to type 2 diabetes mechanisms.
Search MagazineMarch 27, 2018
Helping doctors find the best treatment for cancer
New JAX program is helping oncologists quickly find the most effective cancer treatments for each of their patients.

Research HighlightApril 10, 2018
Cancer research: Beyond the Petri dish
The latest developments in cancer research and their translation to oncology practice offer truly exciting potential for better therapies in the near future.
Press ReleaseApril 05, 2018
PDX Finder — Free global portal for cancer models
First global online catalog of Patient-Derived Xenograft models helps cancer researchers save valuable time.
Research HighlightApril 03, 2018
Calling all structural variants
Structural variants, or SVs, are large DNA sequences that are inserted, inverted, deleted or duplicated within genomes. Finding SVs with short-read seq and analysis methods is difficult, but a new SV identification tool, FusorSV, sets a gold standard for SV detection and analysis.
- Genetic Tools
- Genetics and Genomics
Press ReleaseMarch 26, 2018
Edison Liu elected to Board of Directors of American Association for Cancer Research
The members of the American Association for Cancer Research have elected Jackson Laboratory President and CEO Edison T. Liu, M.D. to serve on the AACR Board of Directors for the 2018-2021 term.
- Cancer/Tumors
- Cancer